The JI
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
 QUICK SEARCH:   [advanced]


     
 


This Article
Right arrow Abstract Freely available
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow Request Permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Bani, L.
Right arrow Articles by Thèze, J.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Bani, L.
Right arrow Articles by Thèze, J.
Right arrowPubmed/NCBI databases
*Gene*GEO Profiles
*HomoloGene*UniGene
*Genetics Home Reference
The Journal of Immunology, 2001, 167: 344-349.
Copyright © 2001 by The American Association of Immunologists

Unstimulated Human CD4 Lymphocytes Express a Cytoplasmic Immature Form of the Common Cytokine Receptor {gamma}-Chain1

Lynda Bani*, Virginie Pasquier2,*, Marko Kryworuchko2,*, Jean Salamero{dagger} and Jacques Thèze3,*

* Unité d’Immunogénétique Cellulaire, Département d’Immunologie, Institut Pasteur; and {dagger} Unité Mixte de Recherche, Centre National de la Recherche Scientifique 144, Laboratoire "Mécanismes Moléculaires du Transport Intracellulaire" Institut Curie, Paris, France


    Abstract
 Top
 Abstract
 Introduction
 Materials and Methods
 Results
 Discussion
 References
 
As a component of various cytokine receptors, common cytokine receptor {gamma}-chain ({gamma}c) is essential in the development of the immune system and plays an important role in different stages of inflammatory and immune responses. Here we establish that resting CD4 T cells and the Jurkat CD4 T cell line do not express the mature form of {gamma}c (64 kDa) recognized by mAb Tugh4. However, these cells constitutively transcribe the corresponding {gamma}c gene. This apparent paradox was solved by the demonstration that polyclonal anti-{gamma}c Abs detected endoglycosidase-H-sensitive immature forms of {gamma}c (54–58 kDa) expressed by quiescent CD4 T lymphocytes and Jurkat cells. Immature {gamma}c is characterized as an intracellular component localized in the endoplasmic reticulum. Pulse-chase analysis shows that the immature {gamma}c is rapidly degraded after synthesis. After activation of CD4 T lymphocytes, and as seen in the CD4 T cell line Kit 225, the endoglycosidase-H-resistant mature form of {gamma}c is detectable at the cell surface and in the endosomal compartment. For the first time, our results demonstrate that a cytokine receptor chain may be constitutively produced as an immature form. Furthermore, this supports the notion that expression of the functional form of {gamma}c may require intracellular interactions with lineage- or subset-specific molecular partners.


    Introduction
 Top
 Abstract
 Introduction
 Materials and Methods
 Results
 Discussion
 References
 
The common cytokine receptor {gamma}-chain ({gamma}c)4 is a critical component of different cytokine-specific receptors of the hemopoietin family such as IL-2, IL-4, IL-7, IL-9, and IL-15 (1, 2, 3). As a component of IL-7R, it participates in the regulation of T cell development, and genetic defects in {gamma}c lead to X-linked SCID (4). At the periphery, {gamma}c is an important chain in IL-2R and as such plays a role in controlling the balance between the activation and apoptosis of immune cells (5, 6). This multifunctional chain is also implicated in the differentiation of TH2 cells and in the control of NK activation and differentiation as an essential component of IL-4R and IL-15R, respectively (7, 8).

The expression and the role of IL-2R in the activation and proliferation of human resting CD4 T lymphocytes has already been analyzed in our laboratory. The IL-2R membrane receptor is composed of at least three distinct proteins with apparent molecular masses of 55 kDa (IL-2R{alpha}), 75 kDa (IL-2 R{beta}), and 64 kDa ({gamma}c) (9). We and others have reported that when PBMC are isolated immediately after blood collection on heparin, no {gamma}c is detectable at the cell surface of CD3 T lymphocytes but is largely expressed at the mRNA level (10, 11, 12). In view of the importance of {gamma}c expression in general, and more particularly during CD4 T cell activation, we undertook exploration of the apparent paradox between cell surface expression and mRNA expression. Using a polyclonal Ab specific for {gamma}c, we showed by confocal microscopy and Western blot that resting CD4 T cells and Jurkat cells express an immature {gamma}c (I.{gamma}c) protein localized in their endoplasmic reticulum (ER). After activation, CD4 T cells and the Kit 225 CD4 T cell line express the mature {gamma}c (M.{gamma}c). Pulse-chase experiments have established the biochemical relationship between the I.{gamma}c and M.{gamma}c. For the first time, our data suggest that a cytokine receptor chain may be expressed as an immature form. Therefore, its maturation may be the target of numerous regulatory processes during lymphocyte development and immune reactions.


    Materials and Methods
 Top
 Abstract
 Introduction
 Materials and Methods
 Results
 Discussion
 References
 
Abs and reagents

Anti-{gamma}c rat mAb Tugh4 (IgG2b) was purchased from PharMingen (San Diego, CA). Goat anti-{gamma}c polyclonal Abs (G{alpha}{gamma}c pAb) were obtained from R&D Systems (Minneapolis, MN). Both reagents were directed against the extracellular portion of human {gamma}c. Polyclonal rabbit Abs directed against the C-terminal portion of {gamma}c were obtained from Santa Cruz Biotechnology (Santa Cruz, CA). Texas Red (TR)-labeled goat anti-rat and rabbit anti-goat IgG were obtained from Jackson ImmunoResearch (West Grove, PA). HRP-labeled goat anti-rat and rabbit anti-goat IgG (H + L) were obtained from Southern Biotechnology Associates (Birmingham, AL).

Purified CD4 T lymphocytes and T cell lines

Highly purified CD4 T cells were prepared by negative selection and activated with anti-CD3 or PHA as previously described (11). Jurkat is a CD4 T cell line provided by O. Acuto (Institut Pasteur, Paris, France). Kit 225 is a CD4 T cell line expressing high- and intermediate-affinity IL-2R (13). YT is a cell line expressing intermediate-affinity IL-2R. B{gamma}- is an EBV-transformed B cell line derived from an X-linked SCID patient and does not express {gamma}c mRNA (14).

mRNA extraction, cDNA synthesis, PCR, and hybridization

cDNA synthesis was performed on 1 µg of total RNA with AMV reverse transcriptase (Boehringer, Mannheim, Germany) for 1 h at 37°C, using an oligo(dT) primer. One-tenth of the cDNA reaction product was then used for PCR amplification. The IL-2R specific primers were as follows: 5'-CCACTCGTCCTGGGACAACC-3' with 5'-CATATGAGCTGGGCTGGGTC-3' for IL-2R{alpha}, 5'-GTGAGCTGCTCCCCGTGAGTC-3' with 5'-GACAGCGTCCGGGCCTCGAAC-3' for IL-2R{beta}, 5'-CGCAGGTGGGTTGAATGAAGGAA-3' with 5'-CCACCCTGAAGAACCTAGAGG-3' for IL-2R{gamma}, and 5'-GGACAGGACTGAACGTCTTGC-3' with 5'-TTCACCAGCAAGCTTGCGACC-3' for hypoxanthine phosphoribosyltransferase.

PCR products were analyzed by Southern blot using 20 pmol of [{gamma}-32P] ATP-labeled oligonucleotide probes and subjected to autoradiography. The oligonucleotides used were 5'-GCAGGCCAGTGGACCAAGCGA-3' for IL-2R{alpha}, 5'-AGCATCCTGGGCCTGCAACC-3' for IL-2R{beta}, 5'-TTGGGGAGGGGCCTGGGGCC-3' for IL-2R{gamma}, and 5'-CCTTGGTCAGGCAGTATAATCC-3' for hypoxanthine phosphoribosyltransferase. The negative controls include a PCR mixture without cDNA as well as non-reverse transcribed mRNA.

Immunofluorescence and confocal microscopy

Cells were prepared for immunofluorescence staining as previously described (15). They were then incubated with G{alpha}{gamma}c pAb or Tugh4 mAb and finally stained with TR-labeled antisera directed against goat or rat IgGs. When indicated, purified CD4 lymphocytes were stained with FITC-labeled anti-CD4 mAb (Dako, Glostrup, Denmark).

Confocal laser scanning microscopy and multiple immunofluorescence analysis were performed using a TCS4D confocal microscope based on a DM microscope interfaced with a mixed gas Argon/Krypton laser (Leica Microsystems, Heidelberg, Germany). Briefly, 512 x 512 pixel images were taken using fixed parameters of acquisition for both the excitation light of the 565-nm wavelength and the detection of the resultant photoemission of the TR in the different cell types or in highly purified CD4 T cells. This allows a comparative view of differences in fluorescence intensities in the different samples, which correspond to differences in the number of recognized Ags per cell.

Metabolic labeling, immunoprecipitation, Western blot analysis, and electrophoresis

Cells were first incubated in RPMI 1640 without methionine and cysteine (ICN Biomedicals, Paris, France) for 45 min at 37°C and then pulse-labeled with 35S Promix (Amersham France, Les Ulis, France) for 15 min at 37°C and chased for various periods of time. At indicated times, 107 cells were chilled in cold PBS and lysed in 1 ml of lysis buffer (1% Triton X-100, 150 mM NaCl, 20 mM Tris-HCl, 5 mM EDTA, 0.2% BSA, and protease inhibitors). Immunoprecipitation, SDS-PAGE, Western analysis, and autoradiography were performed as previously described (15). When indicated, samples were treated with endoglycosidase-H (Endo-H; Boehringer) in 100 mM sodium citrate buffer, pH 5.5, for 12 h at 37°C.


    Results
 Top
 Abstract
 Introduction
 Materials and Methods
 Results
 Discussion
 References
 
Differential expression of {gamma}c at the surface of CD4 T cells

The expression of membrane {gamma}c was analyzed using mAb Tugh4 by flow cytometry at the surface of unstimulated and activated CD4 T cells (Fig. 1Go). IL-2R{alpha} and IL-2R{beta} expression was also analyzed as a control. The expression of the three IL-2R mRNAs was tested by RT-PCR and oligonucleotide hybridization. Results from a representative experiment are shown in Fig. 1Go. Activated CD4 T cells showed membrane expression of IL-2R{alpha}, {beta}, and {gamma}c, and expression of the corresponding mRNA. By contrast, quiescent CD4 T cells, which were negative for the expression of the three subunits at the cell surface, were only positive for {gamma}c at the mRNA level. Similar experiments were performed with two CD4 T cell lines (Fig. 1Go). The Kit 225 cells strongly expressed the three IL-2R chains at the cell surface, whereas the Jurkat cells did not. Like activated CD4 T cells, Kit 225 cells expressed the three IL-2R mRNAs. In contrast, like resting CD4 T cells, Jurkat cells only expressed {gamma}c mRNA. YT and B{gamma}c- cell lines were taken, respectively, as positive and negative control for {gamma}c expression (data not shown).



View larger version (43K):
[in this window]
[in a new window]
 
FIGURE 1. Expression of {gamma}c in different CD4 T cell types. A, IL-2R cell surface expression (11 ). {gamma}c was detected with mAb Tugh4 (dotted line) followed by incubation with an RPE-labeled goat anti-rat IgG. As a control, cells were first incubated with isotype-matched control mAb (solid line). Expressions of IL-2R{alpha}, IL-2R{beta}-chains, and CD4 marker are shown as controls. B, IL-2R mRNA expression (11 ). This was analyzed by RT-PCR and oligonucleotide hybridization on total RNA from the different cells. NA, Nonactivated CD4 T cells; A, activated CD4 T cells; C, negative control corresponding to a PCR mixture in which no cDNA was added; YT, positive control; K, Kit 225 cell line; J, Jurkat cell line; B{gamma}-, B{gamma}- cell line. Data represent one of six separate experiments that gave similar results.

 
Intracellular detection of {gamma}c in unstimulated CD4 T cells

Two immunologic reagents specific for {gamma}c were used to determine its intracellular localization in different CD4 T cells. Confocal microscopic analysis was first performed on resting and activated CD4 T cells (Fig. 2Go, A–D). In activated CD4 T cells incubated with Tugh4 mAb (Fig. 2GoC), {gamma}c staining appeared mainly as bright intracellular vesicles dispersed in the cytoplasm (endosomes). By contrast, resting CD4 T cells displayed no detectable {gamma}c staining with this mAb (Fig. 2GoA). When G{alpha}{gamma}c pAb were used for staining, both resting and activated CD4 T cells were labeled (Fig. 2Go, B and D). This staining was concentrated on the nuclear membrane, suggesting that {gamma}c is localized in the ER. Bright intracellular vesicles were also seen in these cells (Fig. 2GoD).



View larger version (37K):
[in this window]
[in a new window]
 
FIGURE 2. Confocal microscopy analysis of {gamma}c in human CD4 T lymphocytes. Resting (A and B) and activated (C and D) CD4 T lymphocytes were first stained for CD4 marker (green), fixed then permeabilized. {gamma}c location was then revealed by incubating cells with either Tugh4 mAb (A and C) or G{alpha}{gamma}c pAb (B and D). Tugh4 mAb was stained with TR anti-rat IgG. G{alpha}{gamma}c was revealed by TR anti-goat serum. Both give red color for intracellular staining. To evaluate background staining, CD4 lymphocytes were stained with control reagents (E and F). The figure is representative of six separate experiments.

 
A morphological analysis by confocal microscopy of {gamma}c expression in three T cell lines was also undertaken (Fig. 3Go, A–H). The pattern obtained with YT and Kit 225 cells resembled that of activated CD4 T cells (Fig. 3Go, A, B, E, and F). Similarly, Jurkat showed a staining pattern comparable to resting CD4 T cells (Fig. 3Go, C and G). Tugh4 mAb stained vesicles corresponding to the endosomal compartment, whereas G{alpha}{gamma}c pAb stained structures corresponding to the ER as well as the bright vesicles detectable by Tugh4 mAb. The B{gamma}c- cell line, used as a negative control, did not show any staining with Tugh4 or G{alpha}{gamma}c pAb (Fig. 3Go, D and H).



View larger version (19K):
[in this window]
[in a new window]
 
FIGURE 3. Confocal microscopy analysis of {gamma}c in human T cell lines. Cells were fixed and then permeabilized. The localization of the {gamma}c was then revealed by incubating cells with Tugh4 mAb (A–D) or the G{alpha}{gamma}c pAb (E–H), followed by TR anti-rat and anti-goat Abs, respectively. The cell lines analyzed were: YT (A and E), Kit-225 (B and F), and Jurkat (C and G). B{gamma}- cells were used as a negative control (D and H). Fluorescent signals were taken with fixed parameters of acquisition for all cell types. Note in the inset (G) the characteristic ER staining of the nuclear outer membrane. One representative medial optical section is presented. The figure represents one of six separate experiments that gave similar results.

 
I.{gamma}c and M.{gamma}c are selectively identified by G{alpha}{gamma}c pAb and Tugh4 mAb

A Western blot analysis was performed to further understand the molecular basis of {gamma}c intracellular expression in cells that do not express {gamma}c at the surface (Fig. 4Go). In addition, we investigated the biochemical properties of {gamma}c protein in the T cell lines previously studied by fluorescence microscopy. Tugh4 mAb revealed a 64-kDa band in both Kit 225 and in YT cell lines (Fig. 4GoA) corresponding to the previously reported M.{gamma}c expressed at the cell surface (1). By contrast, Tugh4 mAb did not detect the 64-kDa species in the Jurkat cell line (Fig. 4GoA). Parallel experiments were performed using the G{alpha}{gamma}c pAb (Fig. 4GoB). A more complicated pattern was detected in YT and Kit 225 cell lines, showing multiple species in the 54–58 kDa molecular mass range as well as the 64-kDa band. Interestingly, only the 54- to 58-kDa bands were visible in the Jurkat cell line. As expected, the B{gamma}- cell line did not show any detectable bands with Tugh4 or G{alpha}{gamma}c pAb. Immunoprecipitation with Tugh4 mAb followed by Endo-H treatment and detection of the precipitated material by immunoblotting with G{alpha}{gamma}c pAb showed that the 64-kDa band detected in YT and Kit 225 cells was resistant to Endo-H treatment (Fig. 4GoC). Interestingly, direct Western blotting of the nonimmunoprecipitated material from Jurkat and YT cells with the G{alpha}{gamma}c pAb revealed two bands of 54–58 kDa sensitive to Endo-H treatment (Fig. 4GoD). Two new bands of approximately 36 and 39 kDa appeared after Endo-H treatment. The 39-kDa molecular mass band correspond to the predicted molecular mass of the {gamma}c polypeptide. The identity of the 36-kDa band was not clear but could correspond to a degradation product of the 39-kDa band. This suggests that in Jurkat cells {gamma}c is blocked in the early compartments of the biosynthetic secretory pathway.



View larger version (47K):
[in this window]
[in a new window]
 
FIGURE 4. Differential expression of M.{gamma}c and I.{gamma}c by T cell lines. A, Western blot analysis by Tugh4 mAb. Whole cell lysates from YT (Y), Kit 225 (K), Jurkat (J), and {beta}{gamma}- cell lines were prepared and analyzed as described in Materials and Methods. B, Western blot analysis by G{alpha}{gamma}c pAb was performed as in A. C, Immunoprecipitation by Tugh4 mAb. The immunoprecipitate was either treated by Endo-H or left untreated. The resulting material was analyzed by Western blot using G{alpha}{gamma}c pAb. D, Analysis of the material not recognized by Tugh4 mAb. The supernatants of the experiment described in C were either treated by Endo-H or left untreated. The resulting material was analyzed by Western blot using G{alpha}{gamma}c pAb. These data are representative of six individual experiments.

 
Expression of M.{gamma}c and I.{gamma}c in resting and activated CD4 lymphocytes

To further evaluate the physiological relevance of our observation a Western blot analysis of {gamma}c was performed on CD4 T lymphocytes isolated from PBMCs of healthy donors. We established that the CD4 lymphocytes were in fact resting before stimulation by the lack of activation markers (IL-2R{alpha}, CD69) expression on their surface.

Highly enriched CD4 T lymphocytes (>=90% pure) were stimulated with immobilized anti-CD3 or both anti-CD3 and anti-CD28 mAbs. After 1 or 2 days, cells were collected and total cellular protein lysates were subjected to Western blot analysis using different Abs specific for human {gamma}c (Fig. 5Go). Probing with Tugh4 mAb revealed the expression of M.{gamma}c (band of 62–64 kDa) in activated cells but not in unstimulated cells. Costimulation with anti-CD28 mAb did not increase M.{gamma}c expression after 1 or 2 days of stimulation (Fig. 5GoA).



View larger version (54K):
[in this window]
[in a new window]
 
FIGURE 5. Differential expression of M.{gamma}c and I.{gamma}c in resting and activated CD4 lymphocytes. Highly enriched CD4 lymphocytes were cultured either alone or in the presence of anti-CD3 mAb (2 µg/ml) or anti-CD3 mAb + anti-CD28 mAb (10 µg/ml) immobilized on goat anti-mouse Ab-coated plates. After 1 or 2 days of culture cells were harvested and lysates subjected to Western blot analysis as indicated in Materials and Methods. Three reagents were used for the detection of {gamma}c. A, Tugh4 mAb recognizes the M.{gamma}c. B, G{alpha}{gamma}c pAb is directed against the extracellular domain of {gamma}c. C, G{alpha}{gamma}c pAb C-terminal is directed against the C-terminal part of {gamma}c.

 
When G{alpha}{gamma}c pAb was used for Western blot analysis the I.{gamma}c was clearly detected in lysates from unstimulated cells. After stimulation this band increased in intensity and the M.{gamma}c became detectable. Again, costimulation with anti-CD28 mAb did not significantly alter the pattern of the M.{gamma}c and I.{gamma}c expression (Fig. 5GoB). These results were confirmed by the fact that a different pAb, G{alpha}{gamma}c pAb (C terminal), directed against the C-terminal part of {gamma}c, exhibited a similar staining pattern in Western blots (Fig. 5GoC).

Kinetics of {gamma}c maturation in YT and Jurkat T cell lines

We performed pulse-chase labeling experiments to determine precisely the behavior of {gamma}c in the Jurkat cell line (Fig. 6Go). After immunoprecipitation, {gamma}c-specific bands were clearly distinguished from nonspecific bands by their molecular mass (54 or 64 kDa) and pattern of expression. When Jurkat cells were pulse-labeled with [35S]methionine and cysteine for 15 min, a 54-kDa band corresponding to I.{gamma}c was detectable by immunoprecipitation with G{alpha}{gamma}c pAb after 0, 0.5, 1, 2, and 4 h of chase (Fig. 6GoA). No band at 64 kDa was visible in Jurkat cells in the course of the pulse-chase, whereas the mature form of IL-2R{gamma} became apparent in YT cells within 30 min of the chase. As expected, I.{gamma}c in lysates from Jurkat and YT cell lines was Endo-H sensitive, whereas the mature form observed in YT cell lysates was Endo-H resistant. These results were confirmed by immunoprecipitation with Tugh4 mAb. YT cell lysates showed the 64-kDa {gamma}c form after 30 min of chase. By contrast, this mAb did not detect the 64-kDa form in Jurkat cells lysates (Fig. 6GoB). Interestingly, we noted a fairly rapid decrease in the detectable I.{gamma}c in Jurkat cells. This suggests that degradation of this protein occurs early after its neosynthesis. In contrast, in YT cell {gamma}c was at least rescued from degradation by maturation toward the 64-kDa protein and transport forward along the biosynthetic-secretory pathway. These results were fully consistent with our morphological studies in Jurkat cells where I.{gamma}c was detected solely by the G{alpha}{gamma}c pAb and essentially located in the ER.



View larger version (25K):
[in this window]
[in a new window]
 
FIGURE 6. Kinetic analysis of {gamma}c protein maturation in YT and Jurkat T cell lines. The time to appearance of {gamma}c in the Jurkat cell line was studied by pulse-chase and compared with YT cell line as a positive control. Jurkat cells were pulse-labeled with [35S]methionine for 15 min. The different {gamma}c forms were then detected by immunoprecipitation with G{alpha}{gamma}c pAb (A) or Tugh4 mAb (B) after 0-, 0.5-, 1-, 2-, and 4-h chases. The immunoprecipitations conducted on 2-h chase samples were subjected to Endo-H treatment. This experiment was performed twice, and both gave identical results.

 

    Discussion
 Top
 Abstract
 Introduction
 Materials and Methods
 Results
 Discussion
 References
 
{gamma}c is a critical component of IL-2R and therefore participates in the control of CD4 T cell activation, proliferation, and apoptosis (2, 5, 16). In this context, we have previously reported that CD4 lymphocytes constitutively express {gamma}c mRNA. This is in agreement with the finding that {gamma}c promoter lacks TATA motifs and is rich in GC sequences, two criteria which suggest a constitutively transcribed gene (17). Therefore, it was surprising to find that {gamma}c protein is not expressed at the surface of unstimulated quiescent CD4 T cells (11, 12). In this paper, we reconsider this apparent paradox and have characterized a cytoplasmic I.{gamma}c protein constitutively expressed by quiescent CD4 T cells.

Our analysis was conducted on resting and activated CD4 T lymphocytes and on two CD4 T cell lines: Jurkat and Kit 225 (11, 12). Like resting CD4 T cells, Jurkat cells express constitutively {gamma}c mRNA, but the corresponding chain is not detected on their surface (11, 12). By contrast, activated CD4 T cells and the Kit 225 cell line express the three IL-2R chains at their surface and the three corresponding mRNAs. Specific polyclonal Abs against {gamma}c were used to show here that the lack of expression of {gamma}c at the plasma membrane of Jurkat and resting CD4 T cells is not the consequence of an absence of {gamma}c protein synthesis. Western blot and immunoprecipitation detection using G{alpha}{gamma}c pAb confirmed the presence of an immature form of {gamma}c in resting CD4 T lymphocytes and in Jurkat cells. The corresponding bands at 54–58 kDa are Endo-H sensitive. In Jurkat cells, the {gamma}c is only expressed as an immature glycosylated form. By contrast, Tugh4 mAb appeared to recognize only the mature form of the receptor (64 kDa) expressed by activated CD4 lymphocytes and the Kit 225 CD4 cell line.

Pulse-chase experiments further demonstrated that {gamma}c fails to mature in Jurkat cells. This suggests a defect in the transport of this protein out of the early compartments of the biosynthetic secretory pathway. Moreover, the disappearance of the I.{gamma}c glycoprotein indicates that it is degraded intracellularly in Jurkat cells. The persistence of their Endo-H sensitivity suggests that these chains do not pass the medial Golgi compartment before their degradation. In contrast, the I.{gamma}c is partly rescued from degradation in YT cells, which express M.{gamma}c at their cell surface. Taken together, our results demonstrate that {gamma}c is synthesized in unstimulated CD4 T cells and in Jurkat cells but does not gain access to the cell surface.

Confocal microscopic analysis showed specific labeling in both Jurkat and unstimulated CD4 T cells with G{alpha}{gamma}c pAb. {gamma}c distribution was restricted to the nuclear envelope known to be connected with the ER. By contrast, Tugh4 mAb was unable to recognize the ER form of {gamma}c and did not stain Jurkat or resting CD4 T cells. Tugh4 mAb stained intracellular vesicles dispersed throughout the cytoplasm of Kit 225 and activated CD4 T cells. These vesicles likely correspond to the endosomal compartment known to be accessible to internalized cell surface-expressed {gamma}c. Similar {gamma}c staining was found in YT cells. The consistency of the data obtained by confocal microscopy and biochemical analysis using two CD4 T cell lines mimicking the resting and activated states of CD4 T lymphocytes is worthy of note.

It would appear from our results that {gamma}c accumulates in the cytoplasm of resting CD4 T cells and is transported and expressed at the plasma membrane solely after activation, presumably when new molecules are expressed. Association with other polypeptide chains, such as IL-2R{alpha}{beta} subunits, may allow the {gamma}c subunit to be expressed at the plasma membrane. Most of the previous studies suggest that the multimerization of IL-2R chains is highly dependent on the addition of IL-2. However, coimmunoprecipitation of IL-2R subunits has been observed in transfected fibroblast cells and has been obtained in the absence of the natural ligand (18). Therefore, a continuously renewed intracellular pool of {gamma}c would await the induction of the other subunits to be transported to the cell surface. This implies that {gamma}c may contain ER retention signals interacting with ER resident protein. When IL-2R{beta}-chain or IL-2R{alpha}{beta} complex is synthesized following cellular activation, {gamma}c would be handed from the hypothetical ER protein to the IL-2R complex and transported to the plasma membrane. Under these conditions, {gamma}c would escape from the degradation pathway. Other molecules of immunological interest display a similar mechanism of expression. MHC class I molecules require coexpression with {beta}2-microglobulin to be translocated to the cell surface (19). The subunits composing the CD3 complex are also required for cell surface expression of the TCR-{alpha}{beta} heterodimer. The efficiency of TCR assembly in the ER determines receptor density at the surface of T cells; single subunits that fail to join a complex are retained in the ER and subsequently degraded (20). Therefore, on the basis of the results presented and data from the literature, it may be hypothesized that, depending on the cell type and/or the stimuli, {gamma}c associates with different molecular partners (IL-2R{beta}2/15, IL-2R{alpha}{beta}2/15, IL-4R{alpha}, IL-7R{alpha}, IL-9R{alpha}, or yet unknown transporter molecules) before being expressed at the cell surface of thymocytes or lymphocytes.

This is the first time that control at the maturation/cell surface translocation level has been characterized for a cytokine receptor chain. This may be important in T cells for the control of IL-2 response and also for the regulation of CD4 lymphocyte response to IL-4. Because {gamma}c is also an important component of different receptors expressed by different cell types, the control of its maturation may also play a critical role during thymocyte development in response to IL-7 and during mastocyte and NK cell responses mediated by IL-9 and IL-15, respectively.


    Acknowledgments
 
Drs. B. Goud and D. Louvard (Institut Curie) are gratefully acknowledged for their valuable advice. Drs. T. Hori (University of Kyoto) and A. Fisher (Institut National de la Santé et de la Recherche Médicale and Hôpital Necker, Paris) who gave us permission to use Kit 225 and {beta}{gamma}- cell lines are also kindly acknowledged. We thank Drs. O. Acuto and J. Di Santo for critically reading the manuscript. We also thank M. Jones for his help in editing the English manuscript. The expert secretarial assistance of C. Corel is also acknowledged.


    Footnotes
 
1 This work was supported by Caisse Nationale d’Assurance Maladie, Institut Pasteur, and SIDACTION, France. Back

2 V.P. and M.K. contributed equally to this work. Back

3 Address correspondence and reprint requests to Dr. Jacques Thèze, Unité d’Immunogénétique Cellulaire, Département d’Immunologie, Institut Pasteur, 25 rue du Dr Roux, 75724 Paris cedex 15, France. E-mail address: jtheze{at}pasteur.fr Back

4 Abbreviations used in this paper: {gamma}c, common cytokine receptor {gamma}-chain; M.{gamma}c, mature form of {gamma}c; I.{gamma}c, immature form of {gamma}c; G{alpha}{gamma}c pAb, goat anti-{gamma}c polyclonal Abs; ER, endoplasmic reticulum; Endo-H, endoglycosidase-H; TR, Texas Red. Back

Received for publication June 27, 2000. Accepted for publication April 27, 2001.


    References
 Top
 Abstract
 Introduction
 Materials and Methods
 Results
 Discussion
 References
 

  1. Takeshita, T., H. Asao, K. Ohtani, N. Ishii, S. Kumaki, N. Tanaka, H. Munakata, M. Nakamura, K. Sugamura. 1992. Cloning of the {gamma}-chain of the human IL-2 receptor. Science 257:379.[Abstract/Free Full Text]
  2. Leonard, W. J., E. W. Shores, P. E. Love. 1995. Role of the common cytokine receptor {gamma}-chain in cytokine signaling and lymphoid development. Immunol. Rev. 148:97.[Medline]
  3. Malek, T. R., B. O. Porter, Y. W. He. 1999. Multiple {gamma}c-dependent cytokines regulate T-cell development. Immunol. Today 20:71.[Medline]
  4. Fischer, A., J. Disanto, G. de Saint Basile, J.-P. de Villartay, F. Le Deist, J.-L. Casanova. 1999. Cytokines and genetic immunodeficiencies. J. Thèze, ed. The Cytokine Network and Immune Functions 279. Oxford University Press, Oxford.
  5. Smith, K. A.. 1989. The interleukin 2 receptor. Annu. Rev. Cell Biol. 5:397.
  6. Lenardo, M.. 1991. Interleukin-2 programs mouse {alpha}{beta} T lymphocytes for apoptosis. Nature 353:858.[Medline]
  7. Thèze, J., P. M. Alzari, J. Bertoglio. 1996. Interleukin 2 and its receptors: recent advances and new immunological functions. Immunol. Today 10:481.
  8. Jacques, Y., A. Minty, D. Fradelizi, J. Thèze. 1999. Interleukins 2, 4, 7, 9, 13 and 15. J. Thèze, ed. The Cytokine Network and Immune Functions 17. Oxford University Press, Oxford.
  9. Minami, Y., T. Kono, T. Miyazaki, T. Taniguchi. 1993. The IL-2 receptor complex: its structure, function, and target genes. Annu. Rev. Immunol. 11:245.[Medline]
  10. Nakarai, T., M. J. Robertson, M. Streuli, Z. Wu, T. L. Ciardelli, K. A. Smith, J. Ritz. 1994. Interleukin 2 receptor {gamma} chain expression on resting and activated lymphoid cells. J. Exp. Med. 180:241.[Abstract/Free Full Text]
  11. Bani, L., D. David, J.-L. Moreau, A. Cayota, T. Nakarai, J. Ritz, J. Thèze. 1997. Expression of the interleukin-2 receptor {gamma} subunit in resting human CD4 T lymphocytes: mRNA is constitutively transcribed and the protein stored as an intracellular component. Int. Immunol. 9:573.[Abstract/Free Full Text]
  12. David, D., L. Bani, J.-L. Moreau, C. Demaison, K. Sun, O. Salvucci, T. Nakarai, M. de Montalembert, S. Chouaib, M. Joussemet, et al 1998. Further analysis of interleukin-2 receptor subunit expression on the different human peripheral blood mononuclear cell subsets. Blood 91:165.[Abstract/Free Full Text]
  13. Eckenberg, R., R. Rose, J. L. Moreau, R. Weil, F. Gesbert, S. Dubois, D. Tello, M. Bossus, H. Gras, A. Tartar, et al 2000. The first {alpha} helix of interleukin (IL)-2 folds as a homotetramer, acts as an agonist of the IL-2 receptor {beta} chain, and induces lymphokine-activated killer cells. J. Exp. Med. 191:529.[Abstract/Free Full Text]
  14. Hacein Bey, H., M. Cavazzana-Calvo, F. Le Deist, A. Dautry Varsat, C. Hivroz, I. Riviere, O. Danos, J. M. Heard, K. Sugamura, A. Fischer, G. de Saint Basile. 1996. {gamma}c gene transfer into SCID X1 patients’ B-cell lines restores normal high-affinity interleukin-2 receptor expression and function. Blood 87:3108.[Abstract/Free Full Text]
  15. Saudrais, C., D. Spehner, H. D. l. Salle, A. Bohbot, J. Cazenave, B. Goud, D. Hanau, J. Salamero. 1998. Intracellular pathway for the generation of functional MHC class II peptide complexes in immature human dendritic cells. J. Immunol. 160:2597.[Abstract/Free Full Text]
  16. Refaeli, Y., L. V. Parijs, D. A. London, J. Tschopp, A. K. Abbas. 1998. Biochemical mechanisms of IL-2 regulated fas-mediated T cell apoptosis. Immunity 8:615.[Medline]
  17. Noguchi, M., S. Adelstein, X. Cao, W. J. Leonard. 1993. Characterization of the human interleukin-2 receptor {gamma} chain gene. J. Biol. Chem. 268:13601.[Abstract/Free Full Text]
  18. Mulloy, J. C., R. W. Crownley, J. Fullen, W. J. Leonard, G. Franchini. 1996. The human T-cell leukemia/lymphotropic virus type 1 p12I proteins bind the interleukin-2 receptor {beta} and {gamma}c chains and affects their expression on the cell surface. J. Virol. 70:3599.[Abstract]
  19. Quillet, A., F. Presse, C. Marchiol-Fournigault, A. Harel-Bellan, M. Benbunan, H. Ploegh, D. Fradelizi. 1988. Increased resistance to non-MHC-restricted cytotoxicity related to HLA A, B expression. J. Immunol. 141:17.[Abstract]
  20. Yang, M., S. Omura, J. S. Bonifacino, A. M. Weissman. 1998. Novel aspects of degradation of T cell receptor subunits from the endoplasmic reticulum (ER) in T cells: importance of oligosaccharide processing, ubiquitination, and proteasome-dependent removal from ER membranes. J. Exp. Med. 187:835.[Abstract/Free Full Text]



This article has been cited by other articles:


Home page
J. Immunol.Home page
A.-H. Pillet, F. Bugault, J. Theze, L. A. Chakrabarti, and T. Rose
A Programmed Switch from IL-15- to IL-2-Dependent Activation in Human NK Cells
J. Immunol., May 15, 2009; 182(10): 6267 - 6277.
[Abstract] [Full Text] [PDF]


Home page
Mol. Cell. Biol.Home page
P. Legembre, S. Daburon, P. Moreau, F. Ichas, F. de Giorgi, J.-F. Moreau, and J.-L. Taupin
Amplification of Fas-Mediated Apoptosis in Type II Cells via Microdomain Recruitment
Mol. Cell. Biol., August 1, 2005; 25(15): 6811 - 6820.
[Abstract] [Full Text] [PDF]


Home page
Int ImmunolHome page
F. Gesbert, J.-L. Moreau, and J. Theze
IL-2 Responsiveness of CD4 and CD8 lymphocytes: further investigations with human IL-2R{beta} transgenic mice
Int. Immunol., August 1, 2005; 17(8): 1093 - 1102.
[Abstract] [Full Text] [PDF]


This Article
Right arrow Abstract Freely available
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow Request Permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Bani, L.
Right arrow Articles by Thèze, J.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Bani, L.
Right arrow Articles by Thèze, J.
Right arrowPubmed/NCBI databases
*Gene*GEO Profiles
*HomoloGene*UniGene
*Genetics Home Reference


HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS